Hey there, web surfer!

To search and monitor rising trends,
create an account here. It's free.

Join Treendly

live demand report in US

Abbvie Stock

Finance    Medium opportunity   

  

Track this trend
(Monitor this trend over time)
 12 Months
Average: 58.55%
Trend: declining
MOM change: -0.52%
 5 Years
Average: 27.74%
Trend: growing
MOM change: 2.97%

Latest forum discussions

We tracked 103 total in the last 3 months

... U.S. to compete with AbbVie's (ABBV) megablockbuster Humira, ...arthritis and Crohn's disease. AbbVie sold $19.8 billion worth...Ronny Gal laid out how AbbVie will fare amid the rush...major source of revenue for AbbVie," Gal writes. None of this...Humira biosimilars for years. The stock is up 19.4% over ... on the stock. He rates AbbVie stock at Overweight, and has a $155 target price. AbbVie stock closed on...
Published on 2022-01-25 in the ABBV forum
This discussion is in English.
via If approved, Rinvoq would gain access to nearly 200,000 potential patients. The indication could generate $500 million in annual revenue for AbbVie. AbbVie still looks like a great dividend growth stock for income investors. article source
Published on 2022-01-24 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via If approved, Rinvoq would gain access to nearly 200,000 potential patients. The indication could generate $500 million in annual revenue for AbbVie. AbbVie still looks like a great dividend growth stock for income investors. article source
Published on 2022-01-24 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
... today's stock market, AbbVie stock rose 4.6% to 114.67. AbbVie stock is forming ...63, according to MarketSmith.com. AbbVie Stock: Earnings, Sales TopDuring the third ... kept his buy rating on AbbVie stock. AbbVie Raises 2021 Earnings ViewLess bullishly, ...67 a share. That beat AbbVie stock analysts' projection for $12.59 ...www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q3-2021/?src=A00220...
Published on 2021-10-30 in the Strategies forum
This discussion is in English.
... today's stock market, AbbVie stock rose 4.6% to 114.67. AbbVie stock is forming ...63, according to MarketSmith.com. AbbVie Stock: Earnings, Sales TopDuring the third ... kept his buy rating on AbbVie stock. AbbVie Raises 2021 Earnings ViewLess bullishly, ...67 a share. That beat AbbVie stock analysts' projection for $12.59 ...www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q3-2021/?src=A00220...
Published on 2021-10-30 in the Strategies forum
This discussion is in English.
AbbVie (ABBV) The Worst Stock to Buy This January By:...• Drug stock ABBV rarely finishes January in positive territory • AbbVie is one...January, historically, is pharmaceutical concern AbbVie Inc (NASDAQ:ABBV). Per White...the last 10 years, ABBV stock carries the worst average return...of $135.93, would put AbbVie stock just below $127. On the... and NASDAQ OMX PHLX (PHLX), AbbVie stock sports a 50-day call...
Published on 2022-01-07 in the The Lotto Pick Project (LOTTO) forum
This discussion is in English.
AbbVie (ABBV) The Worst Stock to Buy This January By:...• Drug stock ABBV rarely finishes January in positive territory • AbbVie is one...January, historically, is pharmaceutical concern AbbVie Inc (NASDAQ:ABBV). Per White...the last 10 years, ABBV stock carries the worst average return...of $135.93, would put AbbVie stock just below $127. On the... and NASDAQ OMX PHLX (PHLX), AbbVie stock sports a 50-day call...
Published on 2022-01-07 in the The Lotto Pick Project (LOTTO) forum
This discussion is in English.
... Nach aktuellen Schätzungen ist Abbvie dann Mitte 2024/Anfang 2025... Umsätze im Milliardenbereich für Abbvie abwerfen zumal der Anteil ...https://seekingalpha.com/news/3760028-abbvie-posts-encouragi… Beide Studien ...werden. Auch langfristig dürfte Abbvie aus seiner Pipeline heraus ...ausgefallen sind. Gut für Abbvie und die anderen Pharma Unternehmen...://seekingalpha.com/article/4462690-abbvie-stock-fears-…
Published on 2021-10-31 in the Depotbesprechung forum
This discussion is in German.
... Nach aktuellen Schätzungen ist Abbvie dann Mitte 2024/Anfang 2025... Umsätze im Milliardenbereich für Abbvie abwerfen zumal der Anteil ...https://seekingalpha.com/news/3760028-abbvie-posts-encouragi… Beide Studien ...werden. Auch langfristig dürfte Abbvie aus seiner Pipeline heraus ...ausgefallen sind. Gut für Abbvie und die anderen Pharma Unternehmen...://seekingalpha.com/article/4462690-abbvie-stock-fears-…
Published on 2021-10-31 in the Depotbesprechung forum
This discussion is in German.
... 85698. Purchased 700 shares of Abbvie stock last week @112.80. It... buying lots of Abbvie having 1850 shares at one point. The stock kept going down... got rid of all my Abbvie shares $$122. Terrible mistake. Stocks ...
Published on 2021-12-22 in the Throw Down the Gauntlet forum
This discussion is in English.
... 85698. Purchased 700 shares of Abbvie stock last week @112.80. It... buying lots of Abbvie having 1850 shares at one point. The stock kept going down... got rid of all my Abbvie shares $$122. Terrible mistake. Stocks ...
Published on 2021-12-22 in the Throw Down the Gauntlet forum
This discussion is in English.
Teva Pharmaceutical stock surged in premarket trading Tuesday, ...&J, Endo International(ENDP) and Abbvie's(ABBV) Allergan -- of ... tentative ruling issued Monday. Teva stock was more than 7% up...) stock rose 12% in the premarket, while Johnson & Johnson(JNJ) and AbbVie(ABBV...
Published on 2021-11-02 in the Agenus Inc. (AGEN) forum
This discussion is in English.
Teva Pharmaceutical stock surged in premarket trading Tuesday, ...&J, Endo International(ENDP) and Abbvie's(ABBV) Allergan -- of ... tentative ruling issued Monday. Teva stock was more than 7% up...) stock rose 12% in the premarket, while Johnson & Johnson(JNJ) and AbbVie(ABBV...
Published on 2021-11-02 in the Agenus Inc. (AGEN) forum
This discussion is in English.
via When Idera Pharmaceuticals flunked a Phase III melanoma trial with its Toll-like receptor 9 agonist tilsotolimod back in March, executives clung to the hope that separate trials in other cancers would turn up better results. article source
Published on 2021-12-16 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via When Idera Pharmaceuticals flunked a Phase III melanoma trial with its Toll-like receptor 9 agonist tilsotolimod back in March, executives clung to the hope that separate trials in other cancers would turn up better results. article source
Published on 2021-12-16 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
... three screens of the 100-stock COWZ portfolio. Each list includes...% $66.75 $73.47 10% AbbVie Inc. ABBV $240 4.15...% $23.33 $17.60 -25% AbbVie Inc. ABBV $240 4.15...
Published on 2022-01-07 in the MLPs forum
This discussion is in English.
... three screens of the 100-stock COWZ portfolio. Each list includes...% $66.75 $73.47 10% AbbVie Inc. ABBV $240 4.15...% $23.33 $17.60 -25% AbbVie Inc. ABBV $240 4.15...
Published on 2022-01-07 in the MLPs forum
This discussion is in English.
AbbVie Stock Gains After Hiking FY21 Earnings ... October 29, 2021 (Benzinga) Print AbbVie Inc (NYSE: ABBV) reports Q3...% to 51.1%. FY21 guidance: AbbVie raises FY21 adjusted EPS guidance...
Published on 2021-10-29 in the Abbvie forum
This discussion is in English.
AbbVie Stock Gains After Hiking FY21 Earnings ... October 29, 2021 (Benzinga) Print AbbVie Inc (NYSE: ABBV) reports Q3...% to 51.1%. FY21 guidance: AbbVie raises FY21 adjusted EPS guidance...
Published on 2021-10-29 in the Abbvie forum
This discussion is in English.